Valproic Acid News and Research

RSS
Valproic Acid is a drug used to treat epileptic seizures and bipolar disorder and to prevent migraine headaches. It is also being studied in the treatment of Kaposi sarcoma. It is a type of anticonvulsant, antimaniacal, and migraine headache prophylactic.
Finding innovative treatments to help patients with traumatic brain injury

Finding innovative treatments to help patients with traumatic brain injury

FDA approves antibacterial drug to treat complicated urinary tract infections, intra-abdominal infections

FDA approves antibacterial drug to treat complicated urinary tract infections, intra-abdominal infections

New experimental system can rapidly assess pathogenic effects of a drug on baby's brain

New experimental system can rapidly assess pathogenic effects of a drug on baby's brain

Reformulated epileptic drug reaches first clinical trial for medically refractory epilepsy

Reformulated epileptic drug reaches first clinical trial for medically refractory epilepsy

Alzheimer's patients using antiepileptic drugs have twice the risk of pneumonia, study shows

Alzheimer's patients using antiepileptic drugs have twice the risk of pneumonia, study shows

Scientists reprogram mature inhibitory neurons into dopaminergic cells

Scientists reprogram mature inhibitory neurons into dopaminergic cells

Research suggests link between epilepsy and bipolar disorder

Research suggests link between epilepsy and bipolar disorder

Valproic acid exposure results in characteristics linked to autism, zebrafish study shows

Valproic acid exposure results in characteristics linked to autism, zebrafish study shows

Scientists genetically engineer mice that display behavioral hallmarks of human bipolar disorder

Scientists genetically engineer mice that display behavioral hallmarks of human bipolar disorder

Study identifies potential link between genes and treatment response in children with CAE

Study identifies potential link between genes and treatment response in children with CAE

Rare antibiotic compound detected in fungi for first time

Rare antibiotic compound detected in fungi for first time

AES releases new guideline to help physicians treat status epilepticus patients effectively

AES releases new guideline to help physicians treat status epilepticus patients effectively

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

UCI researchers uncover new underlying factor of seizures

UCI researchers uncover new underlying factor of seizures

Antiepileptic monotherapy does not increase intrauterine death risk

Antiepileptic monotherapy does not increase intrauterine death risk

Helsinn's Akynzeo for CINV prevention receives EC approval

Helsinn's Akynzeo for CINV prevention receives EC approval

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Vagus nerve stimulation effective in inhibiting cortical spreading depression

Vagus nerve stimulation effective in inhibiting cortical spreading depression

DNMT1 gene essential to maintain breast and cancer stem cells

DNMT1 gene essential to maintain breast and cancer stem cells